Although testosterone is commonly associated with men, it also plays an important physiological role in women.

Understanding the relationship between testosterone and healthy aging is crucial for both men and women as they navigate their physiological changes.

In women, testosterone is produced by the ovaries and adrenal glands, as well as through conversion of other hormones in peripheral tissues. It contributes to sexual function and participates in several metabolic and physiological processes.

Testosterone concentrations generally decline during reproductive aging, although the relationship between menopause and testosterone is more complex than the abrupt decline in estrogen.

Moreover, the effects of testosterone on healthy aging are being studied to better understand how it influences overall health and vitality in later years.

Importantly, declining testosterone levels do not necessarily indicate a medical disorder or a need for hormone replacement.

Can Testosterone Therapy Benefit Women?

The strongest evidence supporting testosterone therapy in women concerns hypoactive sexual desire disorder (HSDD), characterized by persistently reduced sexual desire that causes personal distress and cannot be better explained by another condition or circumstance.

Research involving postmenopausal women with HSDD has demonstrated modest but clinically meaningful improvements in sexual desire, arousal, sexual satisfaction, and associated distress.

Ultimately, the conversation surrounding testosterone and healthy aging continues to evolve as more research becomes available.

The Global Consensus Position Statement on Testosterone Therapy for Women, endorsed by multiple international medical organizations, identifies HSDD in postmenopausal women as the only indication supported by sufficient high-quality evidence.

Treatment decisions should follow a comprehensive assessment of hormonal, psychological, relationship-related, medication-related, and other medical factors.

What About Testosterone for Energy, Muscle Strength, and Cognitive Health?

Testosterone is increasingly promoted to women as a treatment for fatigue, declining muscle mass, reduced motivation, and symptoms attributed to hormonal aging.

However, clinical evidence does not currently support routine testosterone treatment for these purposes.

Research has not established that testosterone therapy in women:

  • Improves general energy or psychological well-being.

  • Prevents cognitive decline or dementia.

  • Produces clinically meaningful improvements in muscle strength or physical function.

  • Prevents osteoporosis-related fractures.

  • Reduces cardiovascular disease or extends lifespan.

These outcomes remain areas of scientific investigation rather than established indications for treatment.

Why Testosterone Testing in Women Requires Careful Interpretation

Unlike testosterone deficiency in men, there is no universally accepted blood testosterone threshold that establishes a diagnosis of androgen deficiency in otherwise healthy women.

Testosterone concentrations in women are considerably lower than in men, making accurate laboratory measurement more challenging.

When clinically appropriate, evaluation may include total testosterone and sex hormone-binding globulin (SHBG). These measurements can help guide treatment monitoring, but a low testosterone result alone does not diagnose HSDD or justify testosterone replacement.

The patient’s symptoms, menopausal status, medical history, medications, and other potential explanations must be considered before treatment is recommended.

Treatment Options and Safety Considerations

For appropriately selected women with HSDD, low-dose transdermal testosterone may be considered under physician supervision.

There is no FDA-approved testosterone formulation specifically for women in the United States. Consequently, clinicians sometimes prescribe carefully adjusted doses of approved male transdermal formulations off-label.

Treatment should aim to maintain testosterone concentrations within the normal physiological range for premenopausal women, rather than achieve levels typically found in men.

Potential adverse effects include acne, increased facial or body hair, scalp hair thinning, and, with excessive exposure, voice deepening or other masculinizing effects that may be irreversible.

Professional guidelines discourage testosterone pellets, high-dose injections, and formulations producing excessive testosterone concentrations. Compounded preparations are generally not recommended because of concerns about dose consistency and limited safety evidence.

Long-term cardiovascular and breast safety data remain insufficient.

Monitoring Women Receiving Testosterone Therapy

For women in whom treatment is appropriate, clinical monitoring should include assessment of sexual symptoms, adverse effects, and testosterone concentrations.

Professional recommendations generally include baseline total testosterone and SHBG testing, repeat testosterone testing approximately three to six weeks after treatment begins, and periodic reassessment thereafter.

If meaningful improvement does not occur within six months, discontinuation is generally recommended.

Treatment should remain focused on a clearly defined clinical objective rather than indefinite hormonal supplementation.

Testosterone Therapy in Men and Women: Important Differences

Clinical consideration Men Women
Established indication Confirmed symptomatic hypogonadism Postmenopausal HSDD
Diagnostic approach Symptoms plus repeatedly low testosterone Clinical HSDD assessment; no diagnostic testosterone cutoff
Sexual function May improve libido and some sexual symptoms May improve desire and sexual satisfaction
Muscle and bone benefits Can improve lean mass and bone density Insufficient evidence for routine treatment
FDA-approved products Available None specifically approved for women
Long-term longevity benefits Not established Not established

A Personalized Approach to Hormonal Health

At Your Private Physician, we recognize that hormonal health is an important component of comprehensive medical care for both men and women.

However, effective treatment begins with understanding the individual rather than focusing exclusively on laboratory values.

A comprehensive evaluation considers symptoms, medical history, cardiovascular and metabolic health, sleep, medications, menopausal status, and other factors that may influence hormonal function.

When testosterone therapy is clinically justified, careful selection, individualized treatment, and ongoing monitoring are essential.

For many patients, addressing underlying medical conditions and improving sleep, physical activity, nutrition, and metabolic health may provide greater benefits than hormone replacement alone.

The objective of healthy aging is not to recreate the hormone levels of youth, but to preserve function, improve quality of life, and support long-term health through scientifically grounded medical care.

Additional Medical References for the Women’s Section